Vart, Priya;
Jongs, Niels;
Wheeler, David C;
Heerspink, Hiddo JL;
Langkilde, Anna Maria;
Chertow, Glenn M;
(2023)
Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial.
Jama Network Open
, 6
(4)
, Article e2310877. 10.1001/jamanetworkopen.2023.10877.
Preview |
Text
Wheeler_vart_2023_ld_230064_1681831984.66286.pdf Download (438kB) | Preview |
Abstract
This secondary analysis of a randomized clinical trial investigates the relative effectiveness and safety of the sodium-glucose cotransporter-2 inhibitor dapagliflozin for Black vs White patients with chronic kidney disease (CKD) in North and South America.
Type: | Article |
---|---|
Title: | Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1001/jamanetworkopen.2023.10877 |
Publisher version: | https://doi.org/10.1001/jamanetworkopen.2023.10877 |
Language: | English |
Additional information: | © 2023 Vart P et al. JAMA Network Open. This is an open access article distributed under the terms of the CC-BY-NC-ND License. |
Keywords: | Humans, White, Glucosides, Hypoglycemic Agents, Renal Insufficiency, Chronic |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/10169475 |
Archive Staff Only
View Item |